Marshall Wace LLP Purchases 103,072 Shares of KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)
Marshall Wace LLP boosted its position in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) by 691.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 117,978 shares of the specialty pharmaceutical company’s stock after acquiring an additional 103,072 shares during the period. […]
Marshall Wace LLP boosted its position in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) by 691.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 117,978 shares of the specialty pharmaceutical company’s stock after acquiring an additional 103,072 shares during the period. […]
